Wedge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Sell |
24,153
-15
| -0.1% | -$979 | 0.03% | 365 |
|
|
2025
Q1 | $1.62M | Sell |
24,168
-8,048
| -25% | -$539K | 0.03% | 350 |
|
|
2024
Q4 | $1.78M | Sell |
32,216
-26,466
| -45% | -$1.46M | 0.03% | 344 |
|
|
2024
Q3 | $3.5M | Sell |
58,682
-3,279
| -5% | -$196K | 0.06% | 253 |
|
|
2024
Q2 | $3.95M | Sell |
61,961
-18,900
| -23% | -$1.2M | 0.07% | 231 |
|
|
2024
Q1 | $5.59M | Buy |
80,861
+15,330
| +23% | +$1.06M | 0.09% | 213 |
|
|
2023
Q4 | $3.61M | Buy |
65,531
+1,958
| +3% | +$108K | 0.06% | 267 |
|
|
2023
Q3 | $3.69M | Sell |
63,573
-43,905
| -41% | -$2.55M | 0.07% | 260 |
|
|
2023
Q2 | $5.79M | Sell |
107,478
-11,467
| -10% | -$617K | 0.09% | 260 |
|
|
2023
Q1 | $4.72M | Sell |
118,945
-5,325
| -4% | -$212K | 0.08% | 271 |
|
|
2022
Q4 | $5M | Sell |
124,270
-5,485
| -4% | -$221K | 0.08% | 269 |
|
|
2022
Q3 | $4.17M | Buy |
+129,755
| New | +$4.17M | 0.07% | 274 |
|
|
2020
Q2 | – | Sell |
-5,710
| Closed | -$233K | – | 515 |
|
|
2020
Q1 | $233K | Buy |
5,710
+335
| +6% | +$13.7K | ﹤0.01% | 438 |
|
|
2019
Q4 | $331K | Buy |
5,375
+1,016
| +23% | +$62.6K | ﹤0.01% | 456 |
|
|
2019
Q3 | $318K | Sell |
4,359
-3,027
| -41% | -$221K | ﹤0.01% | 474 |
|
|
2019
Q2 | $607K | Buy |
7,386
+586
| +9% | +$48.2K | 0.01% | 430 |
|
|
2019
Q1 | $480K | Buy |
+6,800
| New | +$480K | 0.01% | 460 |
|